The Valley Desk

NCT07722546 · Interventional trial

A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old

Overall registry status Recruiting

Phase 2

Conditions Graves' Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov